Caplin ME - Search Results

1

Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors.

Grenader T, Pavel ME, Ruszniewski PB, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Truong Thanh XM, Caplin ME; CLARINET Study Group. Grenader T, et al. Among authors: caplin me. Anticancer Drugs. 2020 Mar;31(3):216-222. doi: 10.1097/CAD.0000000000000909. Anticancer Drugs. 2020. PMID: 31977567 Free PMC article. Clinical Trial.

2

Comparison of functional imaging and standard CT in evaluation of disease extent in patients with tumours showing neuroendocrine features.

Cwikła JB, Buscombe JR, Mielcarek WA, Caplin ME, Watkinson AJ, Hilson AJ. Cwikła JB, et al. Among authors: caplin me. Nucl Med Rev Cent East Eur. 2001;4(1):27-33. Nucl Med Rev Cent East Eur. 2001. PMID: 14600962

3

Long-term efficacy of low activity meta-[131I]iodobenzylguanidine therapy in patients with disseminated neuroendocrine tumours depends on initial response.

Buscombe JR, Cwikla JB, Caplin ME, Hilson AJ. Buscombe JR, et al. Among authors: caplin me. Nucl Med Commun. 2005 Nov;26(11):969-76. doi: 10.1097/01.mnm.0000184941.06123.b9. Nucl Med Commun. 2005. PMID: 16208174

4

Diagnostic imaging of carcinoid metastases to the abdomen and pelvis.

Cwikła JB, Buscombe JR, Caplin ME, Watkinson AF, Walecki J, Gorczyca-Wiśniewska E, Hilson AJ. Cwikła JB, et al. Among authors: caplin me. Med Sci Monit. 2004 Jun;10 Suppl 3:9-16. Med Sci Monit. 2004. PMID: 16538192

5

Gastroenteropancreatic neuroendocrine tumours.

Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, Caplin M, Delle Fave G, Kaltsas GA, Krenning EP, Moss SF, Nilsson O, Rindi G, Salazar R, Ruszniewski P, Sundin A. Modlin IM, et al. Lancet Oncol. 2008 Jan;9(1):61-72. doi: 10.1016/S1470-2045(07)70410-2. Lancet Oncol. 2008. PMID: 18177818 Review.

6

Molecular genetics of gastroenteropancreatic neuroendocrine tumors.

Toumpanakis CG, Caplin ME. Toumpanakis CG, et al. Among authors: caplin me. Am J Gastroenterol. 2008 Mar;103(3):729-32. doi: 10.1111/j.1572-0241.2007.01777.x. Am J Gastroenterol. 2008. PMID: 18341492 Review.

7

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

Kayani I, Bomanji JB, Groves A, Conway G, Gacinovic S, Win T, Dickson J, Caplin M, Ell PJ. Kayani I, et al. Cancer. 2008 Jun;112(11):2447-55. doi: 10.1002/cncr.23469. Cancer. 2008. PMID: 18383518 Free article.

8

Alpha-fetoprotein and human chorionic gonadotrophin-beta as prognostic markers in neuroendocrine tumour patients.

Shah T, Srirajaskanthan R, Bhogal M, Toubanakis C, Meyer T, Noonan A, Witney-Smith C, Amin T, Bhogal P, Sivathasan N, Warner B, Hochhauser D, Caplin ME. Shah T, et al. Among authors: caplin me. Br J Cancer. 2008 Jul 8;99(1):72-7. doi: 10.1038/sj.bjc.6604428. Epub 2008 Jun 24. Br J Cancer. 2008. PMID: 18577995 Free PMC article.

9

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.

Turner NC, Strauss SJ, Sarker D, Gillmore R, Kirkwood A, Hackshaw A, Papadopoulou A, Bell J, Kayani I, Toumpanakis C, Grillo F, Mayer A, Hochhauser D, Begent RH, Caplin ME, Meyer T. Turner NC, et al. Among authors: caplin me. Br J Cancer. 2010 Mar 30;102(7):1106-12. doi: 10.1038/sj.bjc.6605618. Epub 2010 Mar 16. Br J Cancer. 2010. PMID: 20234360 Free PMC article. Clinical Trial.

10

Circulating tumor cells and EpCAM expression in neuroendocrine tumors.

Khan MS, Tsigani T, Rashid M, Rabouhans JS, Yu D, Luong TV, Caplin M, Meyer T. Khan MS, et al. Clin Cancer Res. 2011 Jan 15;17(2):337-45. doi: 10.1158/1078-0432.CCR-10-1776. Epub 2011 Jan 11. Clin Cancer Res. 2011. PMID: 21224371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

239 results

Search Page